Sugentech Inc (253840) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.059x

Based on the latest financial reports, Sugentech Inc (253840) has a cash flow conversion efficiency ratio of -0.059x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-4.25 Billion ≈ $-2.88 Million USD) by net assets (₩72.28 Billion ≈ $48.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 253840 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Sugentech Inc - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how Sugentech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Sugentech Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sugentech Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Etherstack Plc
AU:ESK
-0.042x
Dc Infotech And Communication Limited
NSE:DCI
-0.242x
Inspirisys Solutions Limited
NSE:INSPIRISYS
0.278x
Actuate Therapeutics, Inc. Common stock
NASDAQ:ACTU
-0.611x
Ascent Solar Technologies, Inc. Common Stock
NASDAQ:ASTI
-0.168x
Ralco Agencies Ltd
TA:RLCO
0.141x
Turism Felix B
RO:TUFE
0.094x
Yura Tech. Co. Ltd
KQ:048430
-0.019x

Annual Cash Flow Conversion Efficiency for Sugentech Inc (2017–2025)

The table below shows the annual cash flow conversion efficiency of Sugentech Inc from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see 253840 stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩76.54 Billion
≈ $51.87 Million
₩-14.65 Billion
≈ $-9.93 Million
-0.191x -147.24%
2024-12-31 ₩97.13 Billion
≈ $65.82 Million
₩-7.52 Billion
≈ $-5.09 Million
-0.077x +28.39%
2023-12-31 ₩112.45 Billion
≈ $76.21 Million
₩-12.15 Billion
≈ $-8.24 Million
-0.108x -149.93%
2022-12-31 ₩140.58 Billion
≈ $95.27 Million
₩30.43 Billion
≈ $20.62 Million
0.216x -44.04%
2021-12-31 ₩100.71 Billion
≈ $68.25 Million
₩38.96 Billion
≈ $26.40 Million
0.387x +67.51%
2020-12-31 ₩63.11 Billion
≈ $42.77 Million
₩14.57 Billion
≈ $9.87 Million
0.231x +239.92%
2019-12-31 ₩24.31 Billion
≈ $16.47 Million
₩-4.01 Billion
≈ $-2.72 Million
-0.165x +18.61%
2018-12-31 ₩15.46 Billion
≈ $10.47 Million
₩-3.13 Billion
≈ $-2.12 Million
-0.203x -831.42%
2017-12-31 ₩-32.81 Billion
≈ $-22.24 Million
₩-909.59 Million
≈ $-616.42K
0.028x --

About Sugentech Inc

KQ:253840 Korea Medical Devices
Market Cap
$48.08 Million
₩70.94 Billion KRW
Market Cap Rank
#22118 Global
#1357 in Korea
Share Price
₩4640.00
Change (1 day)
-4.43%
52-Week Range
₩4490.00 - ₩7900.00
All Time High
₩53604.23
About

Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. The company offers lab tests, including systems and test items; and COVID-19 tests. It also provides point of care testing analyzers and test items for testing of influenza A/B, antibody test, COVID-19 and flu, SARS-CoV-2… Read more